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Introduction
The classic model of retrovirology describes virion budding and 
virion–cell fusion as virus-mediated processes that do not follow 
any normal cell biological pathway (Coffi  n et al., 1997; Goff, 
2001). However, animal cells are capable of secreting proteins 
and lipids in exosomes. Exosomes are single membrane organ-
elles that are secreted from the cell and have a similar size and the 
same topology as retroviral particles (Arienti et al., 1997, 2001, 
2002; Denzer et al., 2000b; Carlin et al., 2001; Fritzsching et al., 
2002; Saez et al., 2003). Exosomes share many additional proper-
ties with retroviral particles, including similar lipid and protein 
compositions. These similarities have raised the possibility that 
retroviruses are “Trojan exosomes” that use the exosome biogen-
esis pathway for virion biogenesis and can also use an exosome 
uptake pathway as an alternative, Env-independent pathway for 
infecting neighboring cells (Gould et al., 2003).
One approach to studying the possible relationship between 
exosomes and retrovirions is to directly compare the composition 
of exosomes with retrovirions released by a given cell type. The 
only study that directly compares exosomes with retrovirions 
was performed with human macrophages, and it identifi  ed sev-
eral similarities between the host cell proteins that were included 
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in or excluded from both exosomes and HIV particles (Nguyen 
et al., 2003). Another approach is to determine whether cells 
bud exosomes and retrovirions from similar or distinct   locations 
of the cell. Several studies in macrophages demonstrated that 
  exosome-like vesicles and HIV particles are formed in a two-
step process. First, outward vesicle budding (outward = away 
from the cytoplasm) at the limiting membrane of endosomes 
generates discrete vesicles, and second, fusion of vesicle-laden 
  endosomes with the plasma membrane secretes vesicles into the 
extracellular milieu (Raposo et al., 2002;   Nydegger et al., 2003; 
Pelchen-Matthews et al., 2003; Ono and Freed, 2004).
These macrophage studies fi  t the common conception 
that exosome biogenesis occurs only by outward budding at 
  endosomal membranes followed by fusion of vesicle-laden 
  endosomes with the plasma membrane (Denzer et al., 2000a; 
Stoorvogel et al., 2002; Thery et al., 2002; Pelchen-Matthews 
et al., 2004). In fact, the dearth of evidence for exosome budding 
at the plasma membrane and the budding of HIV from the 
plasma membrane of T cells (Freed and Martin, 2001; Morita 
and Sundquist, 2004) have been cited as reasons to doubt that 
retroviruses are a variant form of exosomes (Pelchen-Matthews 
et al., 2004). In this study, we examined the cellular distribution 
of exosomal proteins and lipids in the human CD4+ T cell line 
Jurkat and found that exosomal markers colocalized primarily 
at discrete domains of the plasma membrane. We also observed 
presumptive outward budding intermediates at the plasma 
membrane   of Jurkat T cells and found that these structures were 
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xosomes are secreted, single membrane organ-
elles of  100 nm diameter. Their biogenesis is 
typically thought to occur in a two-step process in-
volving (1) outward vesicle budding at limiting mem-
branes of endosomes (outward = away from the 
cytoplasm), which generates intralumenal vesicles, fol-
lowed by (2) endosome–plasma membrane fusion, which 
releases these internal vesicles into the extracellular mi-
lieu as exosomes. In this study, we present evidence that 
certain cells, including Jurkat T cells, possess discrete do-
mains of plasma membrane that are enriched for exo-
somal and endosomal proteins, retain the endosomal 
property of outward vesicle budding, and serve as sites 
of immediate exosome biogenesis. It has been hypothe-
sized that retroviruses utilize the exosome biogenesis 
pathway for the formation of infectious particles. In sup-
port of this, we ﬁ  nd that Jurkat T cells direct the key bud-
ding factor of HIV, HIV Gag, to these endosome-like 
domains of plasma membrane and secrete HIV Gag from 
the cell in exosomes.JCB • VOLUME 172 • NUMBER 6 • 2006  924
  associated with exosomal markers. Moreover, Jurkat T cells 
  appear to treat HIV Gag as an exosomal cargo molecule, sorting 
it to domains of plasma membrane that are enriched in  exosomal 
markers and secreting it from the cell in exosomes.
Results
T cell exosomes are enriched for CD81 
and CD63 but depleted of CD45
Human CD4
+ T cells and certain T cell lines, such as Jurkat 
T cells, are permissive for HIV infection and bud HIV and HIV 
Gag from their plasma membrane (Freed and Martin, 2001). 
To determine whether human T cells also bud exosomes from their
plasma membrane, we fi  rst tested for the presence of known 
  exosomal marker proteins on exosomes that are secreted from 
Jurkat T cells, which were grown under our laboratory conditions.
Jurkat T cells were adapted to growth in serum-free medium, 
and exosomes were collected from the medium by fi  ltration and 
differential centrifugation. The exosome-containing pellet was 
resuspended, subjected to sucrose density gradient centrifugation, 
and fractions across the gradient were assayed for density by 
refractometry and for specifi  c proteins by immunoblotting.
CD81 has previously been detected on the limiting membrane
of endosomes (Fritzsching et al., 2002), is particularly enriched 
in exosomal membranes (Escola et al., 1998; Fritzsching et al., 
2002), and was enriched in exosomes secreted by Jurkat T cells 
grown in serum-free medium (Fig. 1 A, top).  CD63 has also been 
detected on the limiting membrane of endosomes (Metzelaar et al., 
1991) and exosomal membranes (Escola et al., 1998; Heijnen 
et al., 1999; Clayton et al., 2001; van Niel et al., 2001; Blanchard 
et al., 2002; Raposo et al., 2002; van Niel and Heyman, 2002). 
CD63 was abundant in the peak fractions of Jurkat-derived 
Figure 1.  Jurkat T cells sort exosomal proteins  
to discrete domains of the plasma membrane. 
(A and B) Sucrose density gradient analysis of 
exosomes from Jurkat T cells (A) and K562 
cells (B). Densities of the different fractions 
are listed at the top in grams/milliliters. Note 
the signiﬁ  cant enrichment of CD81 and CD63 
in exosome fractions relative to the   levels of 
the proteins in the whole cell lysate (wcl; 
CD81 could not be detected in the whole cell 
lysate sample). The same amount of whole 
cell lysate and gradient fractions were used 
for all three blots. (C–J) Jurkat T cells were pro-
cessed for ﬂ  uorescence microscopy using anti-
bodies   speciﬁ   c for CD81 (C–F) or CD63 
(G–J) under permeabilizing (C, D, G, and H) 
or nonpermeabilizing (E, F, I, and J) condi-
tions. Shown are ﬂ  uorescence (C, E, G, and I) 
and phase-contrast (D, F, H, and J) images of 
representative cells. (K–N) Unpermeabilized 
Jurkat T cells were ﬁ   xed and processed for 
  ﬂ  uorescence microscopy using antibodies spe-
ciﬁ  c for CD81 (K) and CD63 (L). (M) Merge of 
K and L. (N) Phase-contrast image of the cell. 
Bars, 10 μm.HIV IS A TROJAN EXOSOME • BOOTH ET AL. 925
  exosomes, although perhaps not as enriched as CD81 (Fig. 1 A). 
In contrast to CD81 and CD63, the plasma membrane protein 
CD45 is excluded from T cell–derived exosomes (Blanchard 
et al., 2002) and was also excluded from exosomes secreted by 
Jurkat T cells (Fig. 1 A, bottom). Interestingly, CD45 is also 
excluded from T cell–derived HIV virions (Esser et al., 2001; 
Trubey et al., 2003). K562 cells also secreted exosomes that 
were enriched in CD81 and CD63 but lacked CD45 (Fig. 1 B).
Exosomal proteins are enriched at domains 
of the T cell plasma membrane
We next examined the subcellular distribution of CD81 and 
CD63. Immunofl  uorescence analysis of fi  xed and permeabi-
lized Jurkat cells revealed that CD81 was located predominantly 
at the plasma membrane where it was enriched at discrete do-
mains (Fig. 1, C and D), a distribution that was consistent with 
what we observed for CD81 at the surface of fi  xed, unpermeabi-
lized Jurkat cells (Fig. 1, E and F). The subcellular distribution 
of CD63 in permeabilized cells was a bit different, with much of 
the protein residing in internal organelles, although some CD63 
appeared to be at the cell periphery (Fig. 1, G and H). Immuno-
fl  uorescence analysis of fi  xed and unpermeabilized Jurkat cells 
confi  rmed that the CD63 present at the cell periphery was ex-
posed to the extracellular milieu (Fig. 1, I and J). Moreover, 
double-label immunofl  uorescence analysis of fi  xed, unperme-
abilized Jurkat cells revealed that CD81 and CD63 colocalized 
at discrete domains of the T cell surface (Fig. 1, K–N). In 
  contrast, CD45 and 10 other plasma membrane proteins were 
distributed evenly over the surface of these cells (supplemental 
material and Fig. S1, available at http://www.jcb.org/cgi/
 content/full/jcb.200508014/DC1). Similar results were observed 
in K562 cells (not depicted).
Colocalization of exosomal proteins 
and an exosomal lipid
Willem et al. (1990) and Vidal et al. (1997) previously 
established that N-Rh-PE (1,2-dipalmitoyl-sn-glycero-3-
 phosphoethanolamine-N-[lissamine rhodamine B sulfonyl]), a 
fl  uorescent phosphatidyl ethanolamine (PE) analogue, is taken 
up at the plasma membrane of cells, sorted to endosomes, and 
secreted in exosomes. When added to human T cells, N-Rh-PE 
was taken up at the plasma membrane (Fig. 2 A), and, by 1 h, 
much of this lipid had been endocytosed (Fig. 2 B).  However, 
by 3–4 h, a signifi  cant portion of the cell-associated N-Rh-PE 
was present at discrete domains of the plasma membrane. This 
distribution could be detected up to a day (Fig. 2 C) or more   after 
labeling. In addition, N-Rh-PE was secreted from the cells on 
exosomes, which could be captured, bound to coverglasses,
Figure 2.  N-Rh-PE is sorted to discrete domains of the T cell plasma 
  membrane. (A–C) Jurkat cells pulse labeled with N-Rh-PE at 4°C for 1 h were 
washed, returned to growth medium, and examined by ﬂ  uorescence micros-
copy at 0 (A), 1 (B), and 24 (C) h after labeling. (D) 24 h after labeling, 
exosomes were collected, bound to coverglass, and examined by ﬂ  uores-
cence microscopy. (E–L) Unpermeabilized Jurkat cells that had been pulse 
labeled with N-Rh-PE and incubated at 37°C overnight were ﬁ  xed and pro-
cessed for ﬂ  uorescence microscopy using antibodies speciﬁ  c for CD81 (E–H) 
or CD63 (I–L). (M–P) Unpermeabilized Jurkat cells that had been pulse 
  labeled with N-F-PE and incubated at 37°C overnight were ﬁ  xed  and 
  processed for ﬂ  uorescence microscopy using antibodies speciﬁ  c for CD63. 
(Q–T) Unpermeabilized Jurkat cells were pulse labeled with N-Rh-PE for 
1 h, incubated for 16 h at 37°C, pulse labeled with N-F-PE for 1 h, incu-
bated for an additional 16 h at 37°C, and processed for ﬂ  uorescence mi-
croscopy. (U and V) Exosomes were collected from the second 16-h incubation, 
bound to coverglass, and examined by ﬂ  uorescence microscopy. (U) N-Rh-PE–
containing exosomes; (V) N-F-PE–containing exosomes. N-F-PE–containing 
exosomes are marked by white circles. (W–Z) Unpermeabilized Jurkat 
T cells that had been pulse labeled with N-Rh-PE and incubated at 37°C 
overnight were ﬁ  xed and processed for ﬂ  uorescence microscopy using anti-
bodies speciﬁ  c for Lamp1. (A′–D′) Unpermeabilized Jurkat T cells that had 
been pulse labeled with N-Rh-PE were ﬁ  xed, stained with antibodies spe-
ciﬁ  c for CD63, and examined by ﬂ  uorescence microscopy. Primary T cells 
that had been pulse labeled with N-Rh-PE were also examined by ﬂ  uorescence 
microscopy and found to possess single (E′ and F′) or multiple (G′ and H′) 
domains enriched for this lipid. Bars, 10 μm.JCB • VOLUME 172 • NUMBER 6 • 2006  926
and visualized by fl   uorescence microscopy (Fig. 2 D). 
Double-label fl  uorescence microscopy experiments revealed that 
the plasma membrane domains enriched for N-Rh-PE were the 
same as those enriched for CD81 (Fig. 2, E–H) and CD63 (Fig. 2, 
I–L). Jurkat T cells sorted a fl  uorescein-labeled PE derivative, 
N-F-PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-
N-[carboxyfl  uorescein]), in much the same way, as shown by its 
colocalization with surface CD63 (Fig. 2, M–P). When Jurkat T
cells were pulse labeled with N-Rh-PE, incubated for 1 d,
pulse labeled with N-F-PE, and examined 16 h later, one could 
detect the colocalization of these exosomal lipids at discrete do-
mains of the plasma membrane (Fig. 2, Q–T) and their secre-
tion on overlapping populations of exosomes (Fig. 2, U and V). 
Fixed, unpermeabilized, N-Rh-PE–labeled Jurkat T cells were 
also decorated with antibodies specifi  c for the extracellular do-
main of Lamp1. This protein also colocalized with N-Rh-PE, 
although not completely, as Lamp1 was also detected at addi-
tional points along the plasma membrane (Fig. 2, W–Z). Similar 
results were obtained in K562 cells (not depicted).
Approximately one fourth of Jurkat T cells possess a single, 
large domain enriched for these exosomal markers. An even 
greater proportion of the cell population, approximately two 
thirds, possess multiple plasma membrane domains enriched 
for exosomal proteins. The presence of multiple domains was 
evident in cells stained for CD81 and CD63 (such as the middle 
cell in Fig. 1 [I and J] and the upper cell in Fig. 1 [K–N]) and is 
shown here for N-Rh-PE–labeled cells stained for surface CD63 
(Fig. 2, A′–D′). We failed to detect such domains in  10% of 
the cells (for quantitation, see supplemental material). Similar 
results were observed in primary human T cells (Fig. 2, E′–H′).
Domain dynamics
To determine whether these domains remain for just a few sec-
onds or persist for longer periods of time, we examined the 
distribution of N-Rh-PE in live cells by time-lapse microscopy. 
The plasma membrane domains marked by this lipid appeared 
to be semistable, with many of them persisting for periods of 
15 min or more (Fig. 3, A and B).  Similar results were observed 
in K562 cells (Fig. 3, C and D). However, these domains were 
not static entities. Some domains moved laterally in the plasma 
membrane, whereas others formed or dispersed over time, typi-
cally by the movement of smaller domains toward or away from 
one another but also by movement of intracellular organelles to 
the cell surface.
The presence of discrete domains in the T cell plasma 
membrane raises the question of how these domains are orga-
nized and how the cell retains lipids such as N-Rh-PE and 
N-F-PE at these domains. To determine whether membrane lipid 
composition plays a role in retaining N-Rh-PE at these domains, 
we pulse labeled Jurkat T cells with N-Rh-PE for 1 h, incubated 
them for 16 h, exposed them to methyl-β-cyclodextrin for 
30 min to deplete sterols and glycosphingolipids from the plasma 
membrane, removed the methyl-β-cyclodextrin, and followed 
N-Rh-PE distribution over time. Before the addition of methyl-
β-cyclodextrin and after mock treatment, N-Rh-PE is concentrated 
at discrete domains of the plasma membrane (Fig. 3, E and F). 
  Incubation with methyl-β-cyclodextrin for 30 min released a sig-
nifi  cant amount of N-Rh-PE from these domains (Fig. 3, G and H). 
This phenotype was reversible, as removal of the methyl-
β-cyclodextrin allowed Jurkat T cells to redirect N-Rh-PE to 
discrete domains of the plasma membrane (Fig. 3, I and J). Thus, 
it appears that lipid composition is important for the retention of 
N-Rh-PE at discrete domains of the plasma membrane.
Although most Jurkat T cells possess one larger or sev-
eral small discrete domains, there is no reason to presume they 
are present in the plasma membrane of all cells. Monocytic 
cell types, including macrophages and dendritic cells, are one 
group of cells that might be expected to lack such domains. 
Figure 3.  Domain dynamics. (A–D) Jurkat 
T cells (A and B) or K562 cells (C and D) were 
pulse labeled with N-Rh-PE for 1 h, incubated 
overnight, and examined by live cell video 
  microscopy. (E–J) Jurkat T cells were pulse 
  labeled with N-Rh-PE for 1 h, incubated for 
16 h, incubated with 15 mM β-cyclodextrin for 
30 min, washed, and incubated for various 
lengths of time before examination by ﬂ  uores-
cence microscopy. (E and F) Mock-treated cells 
examined at t = 0 after treatment. (G and H) 
β-cyclodextrin–treated cells examined at t = 0 
after treatment. (I and J) Methyl-β-cyclodextrin–
treated cells examined at t = 8 h after treatment. 
(K and L) The monocyte cell line U937 was 
  labeled with N-Rh-PE for 1 h, grown overnight, 
ﬁ  xed, and processed for immunoﬂ  uorescence 
microscopy using FITC-conjugated antibodies 
speciﬁ  c for CD43. Shown are two representa-
tive cells in which the N-Rh-PE (red), surface 
CD43 (green), and phase-contrast images 
have been merged. Bars, 10 μm.HIV IS A TROJAN EXOSOME • BOOTH ET AL. 927
These cells appear to use the delayed mode of exosome biogen-
esis, in which vesicles bud into endosomes, accumulate, and are 
secreted as exosomes when the endosomes fuse with the plasma 
membrane. To test for the presence of discrete domains on the 
plasma membrane of monocytic cells, we pulse labeled the hu-
man monocytic cell line U937 with N-Rh-PE and examined 
N-Rh-PE distribution 1 d later, counterstaining the cells with 
antibodies specifi  c for the plasma membrane protein CD43. 
Unlike Jurkat T cells, which direct N-Rh-PE to discrete domains 
of the plasma membrane, U937 monocytes retain N-Rh-PE in 
discrete endosomes (Fig. 3, K and L).
Outward vesicle budding at discrete 
domains of the plasma membrane
To determine whether these domains of the T cell plasma mem-
brane share any functional similarities with bona fi  de endo-
somal membranes, we examined the subcellular distribution of 
a class E vacuolar protein sorting (VPS) protein, AIP1/VPS31. 
Class E VPS proteins are thought to mediate outward vesicle 
budding from the limiting membrane of endosomes, and AIP1/
VPS31 has been localized to endosomes and implicated in a late 
stage of protein sorting to outward budding vesicles in yeasts 
and in animal cells (Katzmann et al., 2002; Gruenberg and 
Stenmark, 2004). We observed that a human AIP1/VPS31-YFP 
  fusion protein was present at both internal organelles and at 
  discrete domains of the T cell plasma membrane (Fig. 4, A–D).   
A similar distribution was observed for an AIP1/VPS31-DsRed 
fusion protein (Fig. 4, E–H). Another class E VPS protein, 
VPS4, is an ATPase that is also required at a late stage in protein 
sorting to outward budding vesicles. Human VPS4B has pre-
viously been described as largely cytoplasmic (Bishop and 
Woodman, 2000), and we found that a VPS4B-DsRed fusion pro -
tein was localized to the cytoplasm of Jurkat T cells (not depicted). 
However, ATPase-defective forms of VPS4 have been reported 
Figure 4.  Class E VPS proteins at discrete domains of the 
Jurkat T cell plasma membrane. (A–D) Unpermeabilized 
Jurkat T cells expressing AIP1/VPS31-YFP were processed 
for ﬂ   uorescence microscopy using antibodies speciﬁ  c 
for CD81. (A) AIP1/VPS31-YFP. (E–H) Unpermeabilized 
Jurkat T cells expressing AIP1/VPS31-DsRed were pro-
cessed for ﬂ   uorescence microscopy using antibodies 
speciﬁ  c for CD63. (E) AIP1/VPS31-DsRed. (I–S) Unperme-
abilized Jurkat T cells (I–P) or K562 cells (Q–S) expressing 
VPS4B/K180Q-DsRed were processed for ﬂ  uorescence 
microscopy using antibodies speciﬁ   c for CD63. (I, M, 
and Q) VPS4B/K180Q-DsRed. (T–W) N-Rh-PE–labeled 
Jurkat T cells were ﬁ  xed, permeabilized, and processed 
for ﬂ  uorescence microscopy using antibodies speciﬁ  c for 
TSG101. Bars (I–P and T–W), 10 μm; (Q–S) 5 μm.JCB • VOLUME 172 • NUMBER 6 • 2006  928
TSG101/VPS23, also decorated these domains of plasma mem-
brane in some N-Rh-PE–labeled Jurkat T cells (Fig. 4, T–W). 
However, we were unable to detect TSG101-GFP fusion pro-
teins at such domains (not depicted).
The colocalization of outward vesicle budding factors and 
exosomal proteins at discrete domains of the plasma membrane 
indicates that these domains might be sites of outward vesicle 
budding (i.e., sites of exosome biogenesis). To explore this pos-
sibility, we examined Jurkat T cells and K562 cells by electron 
microscopy. Most thin sections of these cells lacked presump-
tive outward vesicle budding intermediates. However, we did 
occasionally detect such structures (Fig. 5, A and B).  Using 
HRP-conjugated secondary antibodies and 3,3′-DAB–based 
cytochemistry for HRP activity (which deposits an electron-
dense reaction product in the vicinity of the antigen), we ob-
served CD63 enrichment at discrete domains of the plasma 
membrane (Fig. 5 C), one of which contained a presumptive 
outward budding intermediate (Fig. 5 D). Such domains were 
more common than presumptive outward vesicle budding inter-
mediates but were still fairly rare. Similar results were obtained 
using anti-CD81 antibodies and 6-nm gold-conjugated second-
ary antibodies. Most regions of the plasma membrane were de-
void of CD81 label (Fig. 5 E), but clusters of CD81 spanning 
1–3 μm of the plasma membrane (Fig. 5, F–I) could be  detected 
in  5% of sections (for quantitation of immunogold labeling, 
see supplemental material).  For those rare cell sections that 
possessed presumptive outward vesicle budding intermedi-
ates ( 1%), CD81 labeling was detected on or near  50% or 
more of the buds (Fig. 5, G and H). N-Rh-PE–labeled Jurkat 
T cells were also examined, this time using rabbit polyclonal 
antibodies specifi  c for rhodamine and mouse monoclonal anti-
bodies specifi  c for CD81 followed by 18-nm gold-conjugated 
anti–mouse IgG secondary antibodies and 6-nm gold- conjugated 
anti–rabbit IgG secondary antibodies. Both markers colocalized 
on presumptive outward budding intermediates (Fig. 5 J). Like 
CD81, N-Rh-PE was detected at discrete domains of the plasma 
membrane (Fig. 5 K). In contrast to what we observed for the 
exosomal markers CD81 and N-Rh-PE, labeling Jurkat T cells 
for the nonexosomal protein CD45 decorated the entirety of the 
plasma membrane (not depicted).
Collectively, these results indicate that there are discrete 
domains of the T cell plasma membrane that are enriched for a 
variety of endosomal and exosomal proteins and are compe-
tent for outward vesicle budding. Because these properties are 
normally associated with endosomes, we propose the term 
“endosome-like domain” to describe these regions of the 
plasma membrane.
HIV Gag buds from endosome-like domains 
of the plasma membrane
We next compared the sorting of HIV Gag in Jurkat T cells to 
that of exosomal proteins and lipids. HIV Gag mimics the 
 budding of the intact retrovirus (Coffi  n et al., 1997; Freed, 1998; 
Freed and Martin, 2001; Garrus et al., 2001; von Schwedler 
et al., 2003; Ono and Freed, 2004), and GFP-tagged forms of HIV 
Gag can be used to follow its biogenesis (Sandefur et al., 1998, 
2000). When expressed in human T cells, HIV Gag-GFP, like 
Figure 5.  Exosomes appear to bud from discrete domains of the Jurkat 
T cell plasma membrane. (A and B) A presumptive outward budding inter-
mediate (nascent exosome) at the plasma membrane of a K562 cell (B) or 
Jurkat T cells (A, left) adjacent to either another outward budding vesicle 
or a completely budded vesicle (A, right). (C and D) HRP/DAB detection 
of CD63 at the Jurkat T cell surface. (C) A cluster of three CD63-positive 
  regions (arrowheads). (D) A higher magniﬁ  cation image of the boxed re-
gion, possibly with a presumptive outward budding intermediate. (E–I). 
  Immunogold labeling of Jurkat T cell cryosections. (E) Most of the Jurkat 
T cell was devoid of label. (F) When CD81 (arrows) could be detected, it 
was typically clustered. (G) CD81 (arrowheads) decorated presumptive 
outward vesicle budding intermediates. (H) A higher magniﬁ  cation view of 
the budding intermediate (boxed area) from G. Arrows denote the posi-
tions of immunogold labeling for CD81. (I) CD81 (arrowheads) can be de-
tected in domains that span micrometers of the plasma membrane. (J and K) 
Immunogold labeling (arrowheads) of Jurkat T cells for N-Rh-PE (6 nm gold) 
and CD81 (18 nm gold). (J) CD81 and N-Rh-PE colocalized at presump-
tive outward budding intermediates. (K) N-Rh-PE was enriched at   discrete 
domains of the plasma membrane. Bars (A, B, D–H, J, and K), 100 nm; 
(C and I) 1 μm. 
to concentrate on endosomal membranes (Babst et al., 1997; 
Bishop and Woodman, 2000; Piper and Luzio, 2001; Katzmann 
et al., 2002), and we detected human VPS4B/K180Q-DsRed at 
the same domains of the plasma membrane as CD63 (Fig. 4, 
I–L) as well as at internal organelles, presumably endosomes 
(Fig. 4, M–P). Similar results were observed in K562 cells 
(Fig. 4, Q–S). An antibody to yet a third class E VPS protein, HIV IS A TROJAN EXOSOME • BOOTH ET AL. 929
HIV Gag, is detected at discrete domains of the plasma mem-
brane (Freed, 1998; Freed and Martin, 2001; Ono and Freed, 
2004). This curiously focal distribution appears to refl  ect the 
traffi  cking of HIV Gag to endosome-like domains of the plasma 
membrane, as demonstrated by its colocalization with surface 
CD81 (Fig. 6, A–D), surface CD63 (Fig. 6, E–H),  N-Rh-PE 
(Fig. 6, I–L), and AIP1/VPS31 (Fig. 6, M–P).  Similar results 
were obtained in K562 cells, which also colocalized VPS4B/
K180Q-DsRed with HIV Gag-GFP (Fig. 6, Q–S). It should be 
noted that HIV Gag was also present at fl  anking regions of the 
plasma membrane, raising the possibility that HIV Gag might 
reach endosome-like domains by lateral sorting within the 
plasma membrane. Moreover, those Jurkat T cells that con-
tained multiple endosome-like domains of plasma membrane 
sorted HIV Gag to each of these domains (Fig. 6, T–W).
The traffi  cking of HIV Gag-GFP to endosome-like do-
mains of the T cell plasma membrane indicates that it buds from 
these domains just as CD81, CD63, and N-Rh-PE bud from these 
domains. To test this directly, we examined Gag-expressing   
T cells and K562 cells by immunoelectron microscopy. During 
budding, HIV Gag oligomerizes to form an electron-dense pro-
tein core, which marks sites of Gag budding. Exosomal markers 
were detected using mouse monoclonal primary antibodies and 
gold-conjugated secondary antibodies. Although most of the 
Jurkat T cell plasma membrane was devoid of budding inter-
mediates, we could occasionally detect nascent HIV Gag buds 
at the surface of Jurkat T cells (Fig. 7 A) in the vicinity of the 
exosomal marker CD81 (Fig. 7, B and C).  Surface labeling of 
K562 cells revealed that the exosomal marker CD63 was also 
present on or near nascent HIV Gag budding intermediates (Fig. 7, 
D–J). Similar results were observed in 293T cells expressing a 
proviral clone of HIV (Fig. 8). 
HIV Gag is secreted in exosomes
Another way to probe the relationship between exosomes and
retroviruses is to collect exosomes secreted by Gag-expressing
Figure 6.  HIV Gag is sorted to endosome-like domains of 
T cells and K562 cells. (A–H) Unpermeabilized Jurkat cells 
  expressing HIV Gag-GFP were processed for ﬂ  uorescence 
  microscopy using antibodies speciﬁ   c for CD81 (A–D) or 
CD63 (E–H). (I–L) Unpermeabilized Jurkat cells pulse labeled 
with N-Rh-PE and expressing HIV Gag-GFP were processed 
for ﬂ   uorescence microscopy. (M–P) Unpermeabilized Jurkat 
T cells expressing AIP1/VPS31-DsRed and HIV Gag-GFP 
were processed for ﬂ   uorescence microscopy. (Q–S) K562 
cells   expressing VPS4BK180Q-DsRed and HIV Gag-YFP were 
processed for ﬂ   uorescence microscopy. (Q) VPS4B-K180Q-
DsRED. (T–W) Unpermeabilized, N-Rh-PE–labeled Jurkat 
T cells expressing HIV Gag-GFP were processed for ﬂ  uores-
cence microscopy. Bars, 10 μm. JCB • VOLUME 172 • NUMBER 6 • 2006  930
cells and test them for the presence of Gag. HIV Gag-
GFP was expressed in Jurkat T cells that had been pulse 
labeled with N-Rh-PE, and exosomes were collected from 
the medium of these cells, bound to poly-l-lysine–coated 
coverglasses, and examined by fl  uorescencemicroscopy. 
Exosomes were detected on the basis of N-Rh-PE fl  uores-
cence (Fig. 9 A) and HIV Gag-GFP fl  uorescence colocalized 
with this exosomal marker (Fig. 9 B). A parallel exosome 
preparation from HIV Gag–expressing cells contained dis-
crete, single membrane organelles of  100-nm diameter, 
which is typical of exosomes, and a subset of these exo-
somes contained prominent electron-dense cores of oligo-
merized HIV Gag (Fig. 9, C and D). Further purifi  cation of 
a similarexosome preparation by sucrose density gradient 
centrifugation revealed that Jurkat T cells secreted HIV Gag 
in vesicles that cofractionated with the exosomal markers 
CD81 and CD63 (Fig. 9 E). Immunoblot analysis for CD45 
demonstrated that these exosome fractions were signifi  cantly 
depleted of contaminating plasma membrane microvesicles, 
which can potentially contaminate exosome preparations 
(Esser et al., 2001; Blanchard et al., 2002; Trubey et al., 
2003). HIV Gag also copurifi  ed with exosomes that were 
secreted by K562 cells (Fig. 9 F), providing additional 
evidence that human cells secrete HIV Gag from the cell 
in exosomes.
Discussion
Most models of exosome biogenesis emphasize a delayed mode 
of synthesis in which vesicle budding occurs at the limiting 
membrane of discrete endosomes, and vesicle secretion occurs 
only later upon endosome–plasma membrane fusion (Denzer 
et al., 2000a; Stoorvogel et al., 2002; Thery et al., 2002; Pelchen-
Matthews et al., 2004). However, there is no a priori basis for 
assuming that exosome budding and exosome secretion must be 
separated in time and space. In this study, we explored the pos-
sibility that human T cells possess endosome-like domains of 
plasma membrane that retain at least one endosomal function: 
outward vesicle budding. We observed that Jurkat T cells do in-
deed possess endosome-like domains of plasma membrane and 
bud exosomes from these domains. Moreover, we found evi-
dence that these cells treat HIV Gag as exosomal cargo, sorting 
it to endosome-like domains of plasma membrane and secreting 
it from the cell in exosomes.
Endosome-like domains in the T cell 
plasma membrane
The enrichment of known endosomal and exosomal proteins at 
discrete domains of the T cell plasma membrane was unex-
pected from most models of exosome biology (Denzer et al., 
2000a; Stoorvogel et al., 2002; Pelchen-Matthews et al., 2004). 
Figure 7.  HIV Gag buds from endosome-like domains of 
Jurkat T cells and K562 cells. (A) Jurkat T cells processed 
for transmission electron microscopy of cryosections pos-
sess nascent HIV Gag buds at their plasma membrane. 
(B and C) Jurkat T cells processed for transmission electron 
microscopy of cryosections using antibodies speciﬁ  c for 
CD81 and gold-conjugated secondary antibodies. 
Arrows highlight immunogold labeling for surface CD81. 
(D–J) K562 cells expressing HIV Gag were ﬁ  xed, surface 
labeled with monoclonal antibodies speciﬁ   c for CD63 
and gold-conjugated secondary antibodies, and 
  processed for electron microscopy. Boxed area in D is 
shown at a higher magniﬁ  cation in E. Arrows and arrow-
heads highlight immunogold labeling for surface CD63. 
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These endosome-like domains are not associated with any obvi-
ous morphological characteristics save for the rare and transient 
outward vesicle budding intermediate. The enrichment of exo-
somal proteins and lipids at these sites raises many interesting 
questions regarding the mechanisms that direct and/or retain 
cargoes at these domains. A contribution of membrane lipid or-
ganization can be inferred from the observation that methyl-β-
cyclodextrin treatment releases N-Rh-PE from these domains. 
It remains to be determined whether the effects are results of a 
general effect on membrane structure or lipid raft involvement 
(Edidin, 2003). Another relevant feature of these domains is that 
they are neither highly transient nor highly stable. Rather, they 
appear to be dynamic entities that persist long enough to serve 
as platforms for exosome biogenesis and perhaps other func-
tions but are not so static as to be permanent features on the 
cell surface. This dynamic instability appears to contribute to 
the variable numbers of endosome-like domains in the plasma 
membrane, their variable size and distribution on the cell 
  surface, and even their absence or low abundance in the plasma 
membrane of certain cell types. Clearly, there is a need for a 
more sophisticated analysis of the structure and dynamics of 
these domains than we have presented here.
Several lines of evidence indicate that endosome-like do-
mains of plasma membrane are sites of exosome budding. First, 
the colocalization of so many exosomal and endosomal mole-
cules at these domains of the T cell plasma membrane is a strong 
indication that they are sites of exosome biogenesis. Second,   
the presence of AIP1/VPS31, VPS4B/K180Q, and TSG101 
  indicates that these domains have at least some of the cellular 
factors that have been implicated in outward vesicle budding. 
Third, electron microscopy analyses of Jurkat T cells revealed 
the presence of exosomal molecules on or near presumptive out-
ward vesicle budding intermediates at the plasma membrane.
Fourth, live cell imaging experiments demonstrated that 
these domains persist for minutes to hours, a time that 
seems   suffi  cient to allow vesicle budding. Collectively, these 
 observations present a compelling argument that exosomes can, 
in certain cells and at certain locations, bud directly from the
plasma membrane.
Immediate versus delayed modes 
of exosome biogenesis
We have referred to the budding of exosomes directly from the 
plasma membrane as the “immediate mode” of exosome biogen-
esis (Gould et al., 2003). This differs from the more accepted 
view of exosome biogenesis as a delayed process, in which 
vesicles bud into discrete endosomes and are subsequently re-
leased upon endosome–plasma membrane fusion (Denzer et al., 
2000a; Stoorvogel et al., 2002; Thery et al., 2002). Although the 
morphological differences between the immediate and delayed 
modes of exosome biogenesis are signifi  cant, there may be only 
slight mechanistic and/or kinetic differences between the two. 
After all, both modes of exosome biogenesis involve outward 
vesicle budding at endosome-like membranes, ferry the same cargo
molecules from the cell, and are associated with the same protein 
sorting machinery. Moreover, even the delayed mode of exosome 
biogenesis requires the formation of endosome-like domains in the 
plasma membrane (Pelchen-Matthews et al., 2004).
The immediate mode of exosome biogenesis has not pre-
viously attracted much attention, and we believe that sampling 
bias has been a contributing factor. The delayed mode of exo-
some biogenesis involves the formation and retention of an 
intermediate structure, the multivesicular endosome (MVE) 
or multivesicular body (MVB), which is large, relatively long 
lived, and, therefore, easy to detect by electron microscopy and 
light microscopy (Denzer et al., 2000a; Stoorvogel et al., 2002; 
Figure 8.  HIV virions bud from the plasma membrane in 
association with CD81. 293T cells expressing a proviral clone 
of HIV were processed for cryoimmunoelectron microscopy 
using antibodies speciﬁ  c for CD81 and gold-conjugated sec-
ondary antibodies. Arrows denote position of gold particles. 
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Thery et al., 2002). In the immediate mode of exosome bio-
genesis, there is no MVE/MVB-like intermediate, and, thus, the 
only morphological evidence for immediate exosome biogene-
sis is the occasional outward vesicle budding intermediate at the 
plasma membrane. These intermediates are much smaller than 
MVEs/MVBs, shorter lived than MVEs/MVBs, and occur only 
at discrete, small, and otherwise unremarkable domains of the 
plasma membrane. In this context, it is understandable that the 
delayed mode of exosome biogenesis has been easier to observe 
than the immediate mode of exosome biogenesis. This bias can, 
however, be minimized by recognizing the existence of both 
modes of exosome biogenesis, by identifying molecular mark-
ers of exosome biogenesis, and by using these markers to iden-
tify sites of exosome biogenesis in future studies.
Retroviral budding
The observation that human T cells bud exosomes from 
  endosome-like domains of plasma membrane allowed us to 
test a key prediction of the Trojan exosome hypothesis (Gould 
et al., 2003). This hypothesis posits that retroviruses are at their 
most fundamental level a variant form of exosome. Thus, it pre-
dicts that cells will treat the key budding factors of retroviruses 
(typically their Gag protein) as cargo of the exosome biogenesis 
pathway. In the specifi  c case of Jurkat T cells, it predicts that 
HIV Gag will be sorted to endosome-like domains and secreted 
from the cell in exosomes. Several lines of evidence confi  rm 
this prediction. First, we observed that HIV Gag colocalizes 
with surface CD81, surface CD63, N-Rh-PE, and AIP1/VPS31, 
demonstrating that Jurkat T cells do indeed sort HIV Gag to 
endosome-like domains of the plasma membrane. Second, elec    -
tron microscopy studies revealed that HIV Gag appears to bud 
from endosome-like domains of the plasma membrane, as evident 
from the presence of exosomal markers on or near presumptive 
HIV Gag budding intermediates at the plasma membrane. Third, 
fl  uorescence microscopy and electron microscopy data indicated 
that HIV Gag is secreted from the cell in exosomes. Fourth, bio-
chemical studies demonstrated that HIV Gag is secreted from 
the cell in vesicles that copurify with exosomes. Fifth, others 
have shown that human T cells exclude CD45 from HIV par-
ticles (Esser et al., 2001; Trubey et al., 2003), and we observed 
that Jurkat T cells fail to enrich CD45 at endosome-like domains 
of the plasma membrane and exclude CD45 from exosomes.
Figure 9.  HIV Gag is secreted from cells in 
exosomes. (A and B) Exosomes were collected 
from Jurkat cells pulse labeled with N-Rh-PE 
and expressing HIV Gag-GFP and were exam-
ined by ﬂ  uorescence microscopy. Circles mark 
secreted vesicles that contain HIV Gag-GFP. 
(C and D) Thin-section electron micrographs of 
exosomes collected from Jurkat cells express-
ing HIV Gag. Arrows denote the position of 
exosomes that contain the electron-dense HIV 
Gag core. (E and F) Immunoblot analysis of 
whole cell lysates (wcl) and sucrose density 
gradient fractions from conditioned media pre-
pared from HIV Gag–expressing (E) Jurkat cells 
and (F) K562 cells. Bars (A and B), 20 μm; 
(C) 500 nm; (D) 100 nm.HIV IS A TROJAN EXOSOME • BOOTH ET AL. 933
These observations have implications for general hypoth-
eses of retroviral biology. The prevailing hypothesis is that 
HIV Gag recruits the outward vesicle budding machinery to the 
plasma membrane, deforms the membrane as it oligomerizes to 
form its core, and, by these and other mechanisms, drives the 
formation of free HIV virions (Freed, 1998; Freed and Martin, 
2001; Morita and Sundquist, 2004; Ono and Freed, 2004). This 
hypothesis, however, seems overly complex because Jurkat 
T cells possess endosome-like domains of plasma membrane 
and bud exosomes from these domains before Gag expression. 
In contrast, the Trojan exosome hypothesis predicts these ob-
servations (Gould et al., 2003), for its core tenet is that cells will 
bud HIV and other retroviruses where they happen to make 
their exosomes. Such a mechanism also explains why mono-
cytes bud HIV into discrete endosomes and secrete them only 
later after endosome–plasma membrane fusion (Raposo et al., 2002; 
Nguyen et al., 2003; Nydegger et al., 2003; Pelchen-Matthews et al., 
2003; Ono and Freed, 2004). Although many predictions of the 
Trojan exosome hypothesis remain to be tested, the available 
data indicate that it is at least a viable, parsimonious hypothesis 
of retroviral biogenesis.
Materials and methods
Cells, plasmids, and antibodies
Jurkat T cells were maintained in a serum-free medium (AIM-V; Invitrogen). 
K562 and primary human T cells were grown/maintained in RPMI 1640 
supplemented with 10% FCS. N-Rh-PE and N-F-PE were obtained from 
Avanti Polar Lipids, Inc. The plasmid that expresses VPS4B(K180Q)-DsRed 
was provided by W. Sundquist (University of Utah, Salt Lake City, UT). The 
HIV Gag expression vector p96ZM651gag-opt was obtained from Y. Li, 
F. Gao, and B.H. Hahn through the National Institutes of Health (NIH) AIDS 
Research and Reference Reagent Program. The Gag-GFP expression vector 
was generated by amplifying the optimized HIV Gag ORF from 
p96ZM651gag-opt using the primers 5′-G  A  A  A  G  G  T  A  C  C  A  T  G  G  G  C  G  C  C  C-
G  C  G  C  C  A  G  C  A  T  C  -3′ and 5′-C  C  C  G  G  A  T  CC  C  T  G  G  C  T  C  A  G  G  G  G  G  T  C  G  C  T-
G  C  C  -3′. The resulting PCR products were digested with Asp718 and BamH1 
and inserted between the Asp718 and BamH1 sites of pcDNA3-GFP.
A sequence-conﬁ  rmed clone (pcDNA3-HIVGag-GFP) with no errors was 
used for the experiments described in this paper. The AIP1/VPS31-YFP and 
-DsRed expression vectors were generated by amplifying a fragment of the 
AIP1 cDNA (synthesized by PCR from a human muscle cDNA library using 
the primers 5′-C  A  A  G  G  T  A  C  C  A  T  G  G  C  G  A  C  A  T  T  C  A  T  C  T  C  G  G  T  G  -3′ and 
5′-C  A  A  G  G  A  T  C  C  C  T  G  C  T  G  T  G  G  A  T  A  G  T  A  A  G  A  C  T  G  -3′), cleaving the fragment 
with Asp718 and BamH1, and inserting it between the Asp718 and 
BamH1 sites of pcDNA3-YFP and pcDNA3-DsRed, respectively. Only 
  sequence-conﬁ  rmed clones lacking undesired mutations were used for 
  experiments. FITC-conjugated anti–human CD63, FITC-conjugated anti–
  human CD81, phycoerythrin-conjugated anti–human CD81, and unlabeled 
monoclonal antibody directed against human CD30 (BerH8) and CD81 
(JS-81) were obtained from BD Biosciences. Unlabeled mouse monoclonal 
antibodies directed against human Lamp1 (H4A3), CD7 (3A1E-12HT), 
CD43 (DF-T1), CD45 (2D-1), and CD63 (H5C6) and polyclonal rabbit 
antibodies speciﬁ  c for CD81 were obtained from Santa Cruz Biotechnology,  
Inc. Rabbit anti-rhodamine antibodies were obtained from Invitrogen.
Polyclonal antibodies directed against HIV Gag were generated against 
puriﬁ  ed p24. Secondary antibodies were obtained from Jackson Immuno-
Research Laboratories. Directly labeled anti-CD63 and anti-CD81 
antibodies were used in Figs. 1 (E–F and I–N), 2 (E–P), 4 (I–P), and 6 (A–L). 
Unlabeled primary antibodies were used in all other experiments.
Transfections, cell manipulations, and light microscopy
5 × 10
6 cells were electroporated with 2 μg of plasmid using a Nucleo-
factor apparatus (Amaxa) and Cell Line Nucleofector Kit V (Amaxa) or by 
using an electroporator (ECM600; BTX) and standard protocols. Pulse la-
beling of cells with N-Rh-PE, N-F-PE, or N-biotin-PE involved solubilizing the 
phospholipid in absolute ethanol, injecting it into cold AIM-V media with 
a Hamilton syringe to a ﬁ  nal concentration of 5 μM, incubating cells in 
this solution for 1 h at 4°C, washing the cell extensively with cold AIM-V 
media, and resuspending the cells in AIM-V medium at 37°C. Labeling of 
transfected cells with N-Rh-PE was performed  14 h after transfection. 
Cells labeled with N-Rh-PE or N-F-PE were ﬁ  xed  20 h after labeling 
unless otherwise stated. Treatment with 15 mM β-cyclodextrin was for 
30 min at 37°C.
For ﬂ  uorescence microscopy, cells were ﬁ  xed with 3% PFA in 1× 
PBS, pH 7.2, for 15 min and washed twice in PBS, all at 20–25°C. For the 
experiments with permeabilized cells (Fig. 1, C, D, G, and H; and Fig. 4, 
T–W), ﬁ  xed cells were incubated in 1% Triton X-100 in 1× PBS, pH 7.2, 
for 5 min followed by two washes in 1× PBS, pH 7.2. After ﬁ  xation or ﬁ  xa-
tion and permeabilization, cells were incubated with either labeled pri-
mary antibodies (experiments in Fig. 1) or sequentially with unlabeled 
primary and labeled secondary antibodies, each diluted in 1× PBS, 
pH 7.2. After the antibody incubations, samples were washed extensively 
in PBS. Before viewing, samples were placed in mounting medium 
(90% glycerol, 100 mM Tris, pH 8.5, and 0.1% paraphenylenediamine). 
Unless otherwise noted, cells were examined at 20–25°C, and images 
were obtained using a ﬂ  uorescence microscope (BH-2; Olympus) equipped 
with a 60× NA 1.4 lens and captured with a CCD camera (Sensicam QE; 
Cooke) linked to a MacG4 computer using IPlab software (Scanalytics). 
Exceptions are listed as follows. Images for Figs. 3 (A–D) and 4 (Q–S) 
were obtained using a confocal ﬂ  uorescence microscope (LSM510 Meta; 
Carl Zeiss MicroImaging, Inc.) with a 63× NA 1.4 lens and dedicated 
imaging software (LSM image browser; Carl Zeiss MicroImaging, Inc.). 
Images for Figs. 2 (E–P), 4 (I–L), 6 (A–L), and 9 (A and B) were obtained 
using an UltraView Live Cell Imaging system (PerkinElmer) with a 63× NA 
1.4 lens (Nikon), a spinning Nipkow disk with microlenses, and UltraView 
software (PerkinElmer). For live cell imaging (Fig. 3, A–D), cells were incu-
bated in growth medium supplemented with 100 mM Hepes on a peltier 
modulated stage warmer (Instec) maintained at 37°C. Digital images were 
false colored, converted to Adobe Photoshop TIFF ﬁ  les, adjusted for bright-
ness and contrast, and assembled in Adobe Illustrator. Fluorochromes for 
labeled primary antibodies are described above. For all experiments using 
secondary antibodies, FITC and Texas red conjugates were used, and 
staining patterns were dependent on prior incubation with primary anti-
bodies. False color images correspond to idealized hues for these ﬂ  uoro-
chromes. For experiments using fusion proteins to ﬂ  uorescent  proteins, 
images correspond to direct ﬂ   uorescence of the fusion protein. Images 
shown are representative of results from a minimum of four replicates of 
each experiment.
Electron microscopy
Immunogold surface labeling of cells was performed essentially as de-
scribed previously (McCaffery and Farquhar, 1995). In brief, cells were 
ﬁ  xed for 1 h at RT in 2% PFA in 100 mM PO4, pH 7.4. Cells were washed, 
blocked in 10% FCS in 100 mM PO4, pH 7.4, for 20 min, and incu-
bated overnight with anti-CD63 antibodies in 100 mM PO4, pH 7.4. After 
washing, cells were incubated for 2 h at RT with donkey anti–mouse 5-nm 
Au conjugate, washed, and again ﬁ  xed for 1 h in 2% glutaraldehyde, 
2.5% sucrose (wt/vol), and 100 mM cacodylate, pH 7.4. The cells were 
spun into a tight pellet, ﬁ  xed in Palade’s osmium for 1 h, en bloc stained 
overnight in Kellenberger’s uranyl acetate, dehydrated through a graded 
series of ethanol, and embedded in epon. 80-nm ultrathin sections were 
cut on an ultramicrotome (model UCT; Leica) collected onto 400 mesh high 
transmission nickel grids, post-stained in uranyl acetate and lead citrate, 
and observed on a transmission electron microscope (EM 410; Philips). 
Immunoperoxidase labeling was performed essentially as described previ-
ously (McCaffery and Farquhar, 1995). In brief, cells were ﬁ  xed in 4% PFA 
and contained in 0.1 M phosphate buffer, pH 7.4, for 1 h at RT. Fixed cells 
were sequentially incubated with primary antibodies, washed, and incu-
bated with HRP-conjugated secondary antibodies, all diluted in 1× PBS. 
Cells were washed in 0.1 M cacodylate-HCl, pH 7.4, and 7.5% sucrose 
followed by postﬁ   xation with 4% glutaraldehyde in 0.1 M cacodylate-
HCl, pH 7.4, for 1 h. Cells were then incubated in DAB reaction buffer 
(3 mg/ml DAB, 0.01% H2O2, and 0.1 M Tris-HCl, pH 4) and postﬁ  xed 
in 0.1 M cacodylate-HCl, pH 7.4, 1% reduced OsO4, and 1% KFeCN. 
Cells were dehydrated through a graded series of ethanol and embedded 
in epon. 80-nm sections were prepared on an ultramicrotome (model UCT; 
Reichert), collected onto nickel grids, and stained with lead citrate. For 
cryoelectron microscopy, cells were ﬁ  xed at 4°C in 100 mM PO4 contain-
ing 2.5% sucrose, pH 7.4, and 4% PFA overnight, washed, and harvested. 
Cell pellets were cryoprotected in 2.3 M sucrose containing 30% polyvinyl 
pyrollidone, mounted on aluminum cryopins, and frozen in liquid nitrogen.
Ultrathin cryosections were then cut on an ultramicrotome (Reichert) 
equipped with an FCS cryostage, and sections were collected onto 300 JCB • VOLUME 172 • NUMBER 6 • 2006  934
mesh formvar/carbon-coated nickel grids. Grids were washed, blocked 
in 10% FCS, and incubated overnight with 10 μg/ml primary antibodies; 
in the case of double indirect labeling, antibodies were mixed. After wash-
ing, grids were incubated with gold-conjugated secondary antibodies for 
2 h, washed, and embedded in a mixture containing 3.2% polyvinyl 
alcohol (10
3 molecular mass), 0.2% methyl cellulose (400 centiposes), and 
0.2% uranyl acetate. Sections were analyzed on a transmission electron 
microscope (Philips), and images were collected with a digital camera 
(Megaview III; Soft Imaging System). Digital images were adjusted for 
brightness and contrast and assembled into ﬁ  gures using Adobe Illustra-
tor or Canvas. Control experiments in which primary antibodies were 
omitted showed no labeling, and primary antibodies used for immuno-
electron microscopy were also tested for labeling speciﬁ  city by immuno-
ﬂ  uorescence microscopy.
Exosome puriﬁ  cation and immunoblotting
Cells were removed from the culture supernatant by centrifugation at 2,000 g 
for 5 min followed by passage of the supernatant through a 0.22-μm ﬁ  lter. 
The supernatant was then subjected to two to three successive spins at 
10,000 g for 30 min to remove cell debris and at 70,000 g for 1 h to pel-
let exosomes. Further puriﬁ  cation of exosomes was accomplished by resus-
pending the 70,000 g pellet fraction and centrifuging the exosome sample 
for 16 h at 270,000 g through a continuous sucrose gradient. 11 fractions 
were collected, assayed for density by refractometry, and particulate 
  material was collected by spinning each sample for 1 h at 350,000 g. 
Pellets were resuspended in 1× SDS-PAGE loading buffer, separated by SDS-
PAGE, and processed for immunoblotting using speciﬁ  c antibodies (mouse 
monoclonal antibodies to CD45 and CD63 and rabbit polyclonal antibod-
ies for CD81 and HIV Gag together with HRP-conjugated secondary anti-
bodies to mouse or rabbit, respectively) followed by chemiluminescent 
detection of HRP-conjugated secondary antibodies. For ﬂ  uorescence  mi-
croscopy of exosomes, 70,000 g exosome pellet fractions were resus-
pended in 1× PBS, pH 7.2, applied to poly-L-lysine–coated coverslips, and 
imaged on a ﬂ   uorescence microscope (BH-2; Olympus) at 20–25°C 
equipped with a 60× NA 1.4 lens, and images were captured using a 
CCD camera (Cooke) linked to a MacG4 computer using IPlab software.
Online supplemental material
Fig. S1 shows the distribution of other plasma membrane proteins on Jurkat 
T cells. Supplemental material provides details about the quantitation of immuno-
ﬂ  uorescence data and immunogold labeling. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200508014/DC1.
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